Sean Purdy

The latest from 340B Report: Growth in 340B Purchases Driven by Pharma Price Increases, Broader Healthcare Trends, Providers Say - https://lnkd.in/dsbpY9PW Magic Johnson-Backed Startup Raises $31 Million to Help Build, Expand In-House Pharmacies at 340B HIV Clinics - https://lnkd.in/dSza-VF7 5 Key Focus Areas in a 340B Audit - https://lnkd.in/erJP3spw 340B Lobbying Activity Did Not Slow Down in Q3, Federal Filings Suggest - https://lnkd.in/dXkqcx8M To get full access to 340B Report news reporting and analysis, visit https://lnkd.in/gJd7qNyg #340B #pharmacy #drugpricing #hospitals #hospitalpharmacy

13

The specialty pharmacy landscape is evolving faster than ever! With advancements like gene therapies, biosimilars, and rare disease treatments, specialty pharmacies are redefining how patients receive complex medications. At MedOp Solutions, we’re not just keeping up—we’re leading the charge.💪 Our dedicated focus on specialty services allows us to provide highly tailored, patient-centric solutions that align with value-based care and innovative cost-management strategies. We're committed to being a reliable partner in this rapidly changing sector, supporting our clients and patients with solutions that enhance quality care and accessibility. 🌐💊 Check out the latest trends shaping specialty pharmacy and our role in this transformative journey! 📖 Read more about these key trends here: AscellaHealth's 2024 report Business Wire s://https://lnkd.in/gnb3Xvzu). #medopsolutions #pharmacy #nowhiring

8

The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents Drug Channels Institute’s (DCI’s) latest analysis finds that participants in the specialty pharmacy market continue to get more diverse—although revenues remain highly concentrated. https://lnkd.in/g9fhUHrh

2

The latest from 340B Report: Sen. Cassidy’s Letters to Drug Manufacturers Welcomed by Drug Industry Trade Group, Draw Skepticism from 340B Provider Advocates - https://lnkd.in/ej5H-HAH CMS Publishes Final Rule on Medicaid Rebates with Significant 340B Implications - https://lnkd.in/eQtt8Rrs 7 Tips to Help Covered Entities Navigate ACA Open Enrollment - https://lnkd.in/ei9xUs7S 340B Report Kicks Off Editorial Roundtable Podcast and YouTube Show - https://lnkd.in/e5HqBUZp Delaware Enacts 340B-PBM Payment Law Without Contract Pharmacy Provisions from Original Version - https://lnkd.in/eU3VrADT PhRMA, HHS Seek Continued Pause on 340B ADR Lawsuit - https://lnkd.in/eezfdyJk AHA Op-Ed Takes Aim at ‘Big Pharma’s’ 340B Program Growth Rhetoric - https://lnkd.in/emtwbTMj Column: CMS Should Heed the Advice of 340B Community on Medicare Negotiations - https://lnkd.in/e56-ZzCP To get full access to 340B Report news reporting and analysis, visit https://lnkd.in/gJd7qNyg #340B #pharmacy #drugpricing #hospitals #hospitalpharmacy

5

In the PBM landscape, pricing often appears similar across the board. However, the real value differentiator lies in how PBMs manage clinical programs. Effective clinical management not only drives cost savings but also ensures optimal patient outcomes. It’s essential to look beyond pricing and focus on the quality of clinical programs when evaluating PBMs. 💊💡 #PBM #TransparentRx #ClinicalManagement #PatientOutcomes #PharmacyBenefits

4

Ouch! This one really hurts. At least, it should hurt the traditional PBM business practice. Limiting care has long been a patient complaint for all types of managed care cost containment. Formulary control, pharmacy contracting, DIR fees, and claw-backs are some of the contentious conduct called into question when PBMs get called onto the carpet for review. This recent case regarding withholding reimbursements because the providers did not want to continue cancer treatment medications that they thought were unnecessary is a real shocker! We know of the waste associated with auto-refill, but this one is ridiculous! Stay tuned. The traditional PBM model will stay in the spotlight and the combination of market and regulatory reform will ultimately win the day! #pbmreform #prescriptiondrugcosts

7

A 340B Report News Alert: PhRMA Sues Mississippi Over New 340B Contract Pharmacy Law - https://lnkd.in/eBQDCeMq To get full access to 340B Report news reporting and analysis, visit https://lnkd.in/gJd7qNyg #340B #pharmacy #drugpricing #hospitals #hospitalpharmacy

3

ordering from SmartSource just got a lot more conveniant. Our app gives you the flexibility you need to order from wherever you are. if you haven't already done so, please download and give it a try. #pharmacy #Smartsource

93

We at the IPC are in collaboration with the NCPA and other pharmacy group purchasing organizations, leading the charge with a campaign to ensure that PBM reform is included in any “must pass” legislation that Congress clears before it adjourns at the end of the year. We believe that PBMs are detrimental to independent pharmacies as well as their patients. This is especially due to their low reimbursement rates, making it difficult for small pharmacies to break even, even if they have good business. Hopefully, we'll see this legislation pass in the next few weeks before Congress convenes in January. Be sure to check out this blog post to learn more about PBM and what you can do to support: https://lnkd.in/gMSAyhHj #PBMReform #PBM #IndependentPharmacy

39

5 Comments

The latest from 340B Report: Exclusive: It’s Not Just Arkansas Anymore: West Virginia Becomes Second State to Start Enforcing Its Contract Pharmacy Access Law - https://lnkd.in/e4uKvkH4 Michigan 340B Contract Pharmacy Access Bill Moves to Full Senate as Legislative Session Nears End - https://lnkd.in/etrjWHrV Questions to Ask as you Evaluate Potential Referral Partners - https://lnkd.in/emYxpbZS State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Arkansas, Missouri - https://lnkd.in/e8SwHH_G Despite Rep. Guthrie’s Previous Support for Legislation Opposed by Most 340B Providers, Groups Praise His Ascension to E&C Chairperson - https://lnkd.in/eSKA3WjM NACHC, ACH Join Forces to Urge Congress for Health Center Funding, Leaving 340B Differences Aside - https://lnkd.in/eF_C2bRM California Health System Presses Federal Appeals Court to Revive 340B Whistleblower Lawsuit Against Four Major Drugmakers - https://lnkd.in/e75anc3w Webinar—Resolving 340B Noncompliance: From Reversals to Refunds - https://lnkd.in/er5NmNum To get full access to 340B Report news reporting and analysis, visit https://lnkd.in/gJd7qNyg. #340B #pharmacy #drugpricing #hospitals #hospitalpharmacy

14

1 Comment

Boost Team Motivation with Employee Bonuses! 💸 Dr. Lisa Faast reviews a member’s bonus program and shares valuable tips for setting one up. No perfect formula—just start, gather feedback, and adjust as needed! 🙌 Find this helpful? Share with fellow pharmacy owners and help them level up too! https://lnkd.in/e9SZbGPY #diversifyrx #independentpharmacy #localpharmacy #communitypharmacy #smallpharmacyowner #smallbusinessowner #EmployeeBonuses #TeamMotivation #EmployeeEngagement

4

Can we avoid repeating past mistakes with #biosimilars? As more #lowercost alternatives to high-cost #biologics are launched, high barriers – from formulary delays to rebate structures – are slowing their adoption. In his latest article for Pharmacy Times, Chief Pharmacy Officer Mark Campbell, PharmD, explains why the launch of #Humira biosimilars fell short of expectations and how we can seize new opportunities as biosimilars for Stelara and other blockbuster medications come to market. Read more on how overcoming these challenges could transform pharmacy costs and access: https://rxbene.fit/4fF7aEm #PharmacyBenefits

13

𝗖𝗮𝘀𝗵 𝗙𝗹𝗼𝘄 𝗦𝘁𝗿𝗲𝘀𝘀... 𝗕𝗲 𝗚𝗼𝗻𝗲! Day 3 of 12 Days of Christmas for Pharmacy Owners 🎁 Still feeling strapped for cash despite the DIR Fee changes? You’re not alone—but you CAN fix it. 🎁 Today’s Gift: 7 Cash Flow Secrets Webinar – Unlocked for You! Learn how to: ✅ Spot cash flow problems before they snowball ✅ Maximize your profit margins ✅ Take control of your pharmacy’s financial future ✅ Click the link to unlock the secrets and improve your cash flow today! 🔗 Watch the Webinar Now: https://lnkd.in/eQfixXU2 #PharmacySuccess #CashFlowSecrets #PharmacyProfit #BusinessGrowth

Physician burnout, lack of access, and the sliding reputation of Big Pharma has led to large swaths of Americans relying on their local pharmacies more and more to be their first point of care. According to a recent survey of patients: 💊 83% of patients said they placed a a very high level of trust in their pharmacists’ decision-making when it comes to their medications and treatment regimen. The highest among healthcare professionals. 💊 86% of patients are open to pharmacists providing additional clinical services 💊 77% of patients said their pharmacists were an integral part of their care teams 💊 69% of patients saying they were vaccinated by a pharmacist 💊 44% of patients reporting getting tested at a pharmacy.  💊 27% said they had received a personalized medication review at pharmacies. 💊 Patients see the same pharmacist for 6.5 years on average — longer than the average of 5.8 years they went to their primary care physician. Check out the article for more info. If you are interested in engaging with pharmacists working in retail, hospital, specialty, or oncology, let's talk!

5

#CASESTUDY: Strategy Development for Long Term Care Access 👇 Need strategic support for your SP #network? Archbow Subject Matter Experts like Kristy Frizzo and Nakul Desai, PharmD have real-world experience helping manufacturers optimize their #SpecialtyPharmacy channels. Ready to take your business to the next level?

9